CSPC Innovation Valuation

300765 Stock   28.51  0.27  0.94%   
At this time, the firm appears to be overvalued. CSPC Innovation Phar shows a prevailing Real Value of USD24.24 per share. The current price of the firm is USD28.51. Our model approximates the value of CSPC Innovation Phar from analyzing the firm fundamentals such as profit margin of 0.25 %, and Return On Equity of 0.11 as well as examining its technical indicators and probability of bankruptcy.
Price Book
10.5012
Enterprise Value
38.8 B
Enterprise Value Ebitda
63.6877
Price Sales
19.7826
Trailing PE
77.0541
Overvalued
Today
28.51
Please note that CSPC Innovation's price fluctuation is not too volatile at this time. Calculation of the real value of CSPC Innovation Phar is based on 3 months time horizon. Increasing CSPC Innovation's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since CSPC Innovation is currently traded on the exchange, buyers and sellers on that exchange determine the market value of CSPC Stock. However, CSPC Innovation's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value.
Historical Market  28.51 Real  24.24 Hype  29.09 Naive  30.26
The real value of CSPC Stock, also known as its intrinsic value, is the underlying worth of CSPC Innovation Phar Company, which is reflected in its stock price. It is based on CSPC Innovation's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of CSPC Innovation's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
24.24
Real Value
28.81
Upside
Estimating the potential upside or downside of CSPC Innovation Pharmaceutical helps investors to forecast how CSPC stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of CSPC Innovation more accurately as focusing exclusively on CSPC Innovation's fundamentals will not take into account other important factors:
Earnings
Estimates (0)
LowProjectedHigh
0.020.050.07
Details
Hype
Prediction
LowEstimatedHigh
24.5229.0933.66
Details
Naive
Forecast
LowNext ValueHigh
25.6930.2634.83
Details

CSPC Innovation Cash

3.59 Billion

CSPC Innovation Total Value Analysis

CSPC Innovation Pharmaceutical is presently forecasted to have takeover price of 38.75 B with market capitalization of 40.42 B, debt of 544.96 M, and cash on hands of . Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the CSPC Innovation fundamentals before making investing decisions based on enterprise value of the company

CSPC Innovation Investor Information

About 79.0% of the company shares are owned by insiders or employees . The company last dividend was issued on the 25th of April 2024. CSPC Innovation Phar had 1.2:1 split on the 25th of April 2024. Based on the analysis of CSPC Innovation's profitability, liquidity, and operating efficiency, CSPC Innovation Pharmaceutical is not in a good financial situation at this time. It has a very high probability of going through financial hardship in December.
Current ValueLast YearChange From Last Year 10 Year Trend
Total Cash From Operating Activities973.6 M927.2 M
Sufficiently Up
Slightly volatile
Operating Income453.3 M783.1 M
Way Down
Slightly volatile

CSPC Innovation Asset Utilization

The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. CSPC Innovation has an asset utilization ratio of 44.42 percent. This suggests that the Company is making USD0.44 for each dollar of assets. An increasing asset utilization means that CSPC Innovation Pharmaceutical is more efficient with each dollar of assets it utilizes for everyday operations.
 
Covid

CSPC Innovation Ownership Allocation

CSPC Innovation holds a total of 1.4 Billion outstanding shares. CSPC Innovation Pharmaceutical shows majority of its outstanding shares owned by insiders. An insider is usually defined as a corporate executive, director, member of the board or institutional investor who own at least 10% of the company's outstanding shares. 78.56 percent of CSPC Innovation Phar outstanding shares that are owned by insiders signifies that they have been buying or selling the stock in recent months in anticipation of some upcoming event. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.

CSPC Innovation Profitability Analysis

The company reported the revenue of 2.5 B. Net Income was 755.56 M with profit before overhead, payroll, taxes, and interest of 1.13 B.
Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates CSPC Innovation's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in CSPC Innovation and how it compares across the competition.

About CSPC Innovation Valuation

The stock valuation mechanism determines CSPC Innovation's current worth on a weekly basis. Our valuation model uses a comparative analysis of CSPC Innovation. We calculate exposure to CSPC Innovation's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of CSPC Innovation's related companies.
Last ReportedProjected for Next Year
Gross Profit1.1 B806.6 M

CSPC Innovation Quarterly Retained Earnings

1.43 Billion

Complementary Tools for CSPC Stock analysis

When running CSPC Innovation's price analysis, check to measure CSPC Innovation's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CSPC Innovation is operating at the current time. Most of CSPC Innovation's value examination focuses on studying past and present price action to predict the probability of CSPC Innovation's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CSPC Innovation's price. Additionally, you may evaluate how the addition of CSPC Innovation to your portfolios can decrease your overall portfolio volatility.
Fundamental Analysis
View fundamental data based on most recent published financial statements
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Commodity Directory
Find actively traded commodities issued by global exchanges